Ernexa Therapeutics Inc.ERNANASDAQ
Loading
EV to Sales HistoryFair Value
Percentile Rank89
5Y CAGR+112.4%
Year-over-Year Change
Enterprise value to sales ratio
5Y CAGR
+112.4%/yr
Long-term compound
Percentile
P89
Within normal range
vs 5Y Ago
43.3x
Strong expansion
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 213.39 | -91.8% |
| 2023 | 2613.91 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | -100.0% |
| 2019 | 4.93 | +44.1% |
| 2018 | 3.42 | -53.4% |
| 2017 | 7.34 | -33.2% |
| 2016 | 11.00 | +19.9% |
| 2015 | 9.18 | - |